File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3389/fimmu.2020.00400
- Scopus: eid_2-s2.0-85082561031
- PMID: 32218786
- WOS: WOS:000525530200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Multiplex screening assay for identifying cytotoxic CD8+ T Cell Epitopes
Title | Multiplex screening assay for identifying cytotoxic CD8+ T Cell Epitopes |
---|---|
Authors | |
Keywords | influenza Plasmodium MERS CD8 T cell cytotoxicity |
Issue Date | 2020 |
Publisher | Frontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/immunology |
Citation | Frontiers in Immunology, 2020, v. 11, p. article no. 400 How to Cite? |
Abstract | The cytotoxicity of epitope-specific CD8+ T cells is usually measured indirectly through IFNγ production. Existing assays that directly measure this activity are limited mainly to measurements of up to two specificities in a single reaction. Here, we develop a multiplex cytotoxicity assay that allows direct, simultaneous measurement of up to 23 different specificities of CD8+ T cells in a single reaction. This can greatly reduce the amount of starting clinical materials for a systematic screening of CD8+ T cell epitopes. In addition, this greatly enhanced capacity enables the incorporation of irrelevant epitopes for determining the non-specific killing activity of CD8+ T cells, thereby allowing to measure the actual epitope-specific cytotoxicity activities. This technique is shown to be useful to study both human and mouse CD8+ T cells. Besides, our results from human PBMCs and three independent infectious animal models (MERS, influenza and malaria) further reveal that IFNγ expression by epitope-specific CD8+ T cells does not always correlate with their cell-killing potential, highlighting the need for using cytotoxicity assays in specific contexts (e.g., evaluating vaccine candidates). Overall, our approach opens up new possibilities for comprehensive analyses of CD8+ T cell cytotoxicity in a practical manner. |
Persistent Identifier | http://hdl.handle.net/10722/289542 |
ISSN | 2023 Impact Factor: 5.7 2023 SCImago Journal Rankings: 1.868 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Poh, CM | - |
dc.contributor.author | Zheng, J | - |
dc.contributor.author | Channappanavar, R | - |
dc.contributor.author | Chang, ZW | - |
dc.contributor.author | Nguyen, THO | - |
dc.contributor.author | Rénia, L | - |
dc.contributor.author | Kedzierska, K | - |
dc.contributor.author | Perlman, S | - |
dc.contributor.author | Poon, LLM | - |
dc.date.accessioned | 2020-10-22T08:14:06Z | - |
dc.date.available | 2020-10-22T08:14:06Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Frontiers in Immunology, 2020, v. 11, p. article no. 400 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | http://hdl.handle.net/10722/289542 | - |
dc.description.abstract | The cytotoxicity of epitope-specific CD8+ T cells is usually measured indirectly through IFNγ production. Existing assays that directly measure this activity are limited mainly to measurements of up to two specificities in a single reaction. Here, we develop a multiplex cytotoxicity assay that allows direct, simultaneous measurement of up to 23 different specificities of CD8+ T cells in a single reaction. This can greatly reduce the amount of starting clinical materials for a systematic screening of CD8+ T cell epitopes. In addition, this greatly enhanced capacity enables the incorporation of irrelevant epitopes for determining the non-specific killing activity of CD8+ T cells, thereby allowing to measure the actual epitope-specific cytotoxicity activities. This technique is shown to be useful to study both human and mouse CD8+ T cells. Besides, our results from human PBMCs and three independent infectious animal models (MERS, influenza and malaria) further reveal that IFNγ expression by epitope-specific CD8+ T cells does not always correlate with their cell-killing potential, highlighting the need for using cytotoxicity assays in specific contexts (e.g., evaluating vaccine candidates). Overall, our approach opens up new possibilities for comprehensive analyses of CD8+ T cell cytotoxicity in a practical manner. | - |
dc.language | eng | - |
dc.publisher | Frontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/immunology | - |
dc.relation.ispartof | Frontiers in Immunology | - |
dc.rights | This Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | influenza | - |
dc.subject | Plasmodium | - |
dc.subject | MERS | - |
dc.subject | CD8 T cell | - |
dc.subject | cytotoxicity | - |
dc.title | Multiplex screening assay for identifying cytotoxic CD8+ T Cell Epitopes | - |
dc.type | Article | - |
dc.identifier.email | Poon, LLM: llmpoon@hkucc.hku.hk | - |
dc.identifier.authority | Poon, LLM=rp00484 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3389/fimmu.2020.00400 | - |
dc.identifier.pmid | 32218786 | - |
dc.identifier.pmcid | PMC7078160 | - |
dc.identifier.scopus | eid_2-s2.0-85082561031 | - |
dc.identifier.hkuros | 317014 | - |
dc.identifier.volume | 11 | - |
dc.identifier.spage | article no. 400 | - |
dc.identifier.epage | article no. 400 | - |
dc.identifier.isi | WOS:000525530200001 | - |
dc.publisher.place | Switzerland | - |
dc.identifier.issnl | 1664-3224 | - |